SIIRD is proud to launch the Strategic Sector Programme, whereby R&D projects which involve at least one research performer from Israel and one research performer from Singapore, can stand to receive enhanced funding support from SIIRD.
The Strategic Sector Programme is now open to projects in the healthtech space, and the deadline for Full submissions is 4 Jul 2024.* Interest applicants are encouraged to submit their applications early in case of technical difficulties.
* Selected applicants will be notified via email to send in the full set of proposal documents.
The support parameters and requirements for the Strategic Sector Programme are as follows:
Grant co-funding |
Between 50% to 66% of the total qualified project cost, or a total of US$3M, whichever is lower |
||||||||||||||||||||||||||||||||||||||||||||||||||
Maximum supportable project duration |
3 years (36 months) |
||||||||||||||||||||||||||||||||||||||||||||||||||
Consortium composition requirements |
An applicant consortium must comprise of minimally:
Each country can involve at most 3 organisations, i.e. the maximum allowable size of an applicant consortium is 6 organisations. In sum, this means that consortiums have to be structured in one of the following ways:
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Special conditions |
Regardless of whether there are 2, 3, or 4 researchers in the consortium, the budget allocated to research performers must not exceed 30% of the proposed total cost of the project. |
||||||||||||||||||||||||||||||||||||||||||||||||||
Additional benefits |
Research performers will not be subject to any of SIIRD’s grant repayment obligations or mechanisms |